Literature DB >> 3039405

Naloxone-induced depolarization and synaptic activation of myenteric neurons in morphine-dependent guinea pig ileum.

S M Johnson, J T Williams, M Costa, J B Furness.   

Abstract

To investigate the cellular basis of opiate dependence, intracellular microelectrodes were used to record from both electrophysiologically defined classes of neurons (S and AH) in myenteric plexus longitudinal muscle preparations from morphine pretreated guinea pigs. These preparations responded to naloxone with the characteristic contraction of the longitudinal smooth muscle, indicative of morphine dependence. Depolarization in response to naloxone was observed in 42% of S neurons, but there were no consistent changes in input resistance. In some cells the depolarization was reduced or abolished after blockade of synaptic transmission, suggesting that it was due in part to the release of an excitatory transmitter producing a slow depolarization in the impaled neuron. Synaptic activation of S neurons during withdrawal was further indicated by the observation that fast postsynaptic potentials appeared after abrupt displacement of morphine from its receptors by naloxone. Morphine withdrawal, therefore, involves both the final motor neurons and interneurons. During naloxone-induced withdrawal, 25% of S neurons discharged action potentials. In contrast, no action potentials were discharged in AH neurons. Furthermore, naloxone did not alter the resting membrane potential, input resistance, soma action potential configuration, or slow hyperpolarization following a soma spike in AH neurons. The specificity of the withdrawal response for S neurons and the relatively small proportion of neurons involved suggests that morphine withdrawal occurs in quite specific neuronal circuits in the myenteric plexus.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3039405     DOI: 10.1016/0306-4522(87)90145-x

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  8 in total

1.  Morphine tolerance and nonspecific subsensitivity of the longitudinal muscle myenteric plexus preparation of the guinea-pig to inhibitory agonists.

Authors:  D A Taylor; J A Leedham; N Doak; W W Fleming
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-11       Impact factor: 3.000

2.  The in vitro pharmacological profile of TD-1211, a neutral opioid receptor antagonist.

Authors:  Pamela R Tsuruda; Ross G Vickery; Daniel D Long; Scott R Armstrong; David T Beattie
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-04-04       Impact factor: 3.000

3.  Pharmacological examination of contractile responses of the guinea-pig isolated ileum produced by mu-opioid receptor antagonists in the presence of, and following exposure to, morphine.

Authors:  M K Mundey; A Ali; R Mason; V G Wilson
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

4.  Effect of clonidine, nimodipine and diltiazem on the in vitro opioid withdrawal response in the guinea-pig ileum.

Authors:  M J Alfaro; M I Colado; F López; M I Martín
Journal:  Br J Pharmacol       Date:  1990-12       Impact factor: 8.739

5.  Evidence for functional dissociation of dependence and tolerance in guinea-pig isolated ileal segments following 20 hour exposure to morphine in vitro.

Authors:  C David; N Davis; R Mason; V G Wilson
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

6.  Opioid dependence in myenteric neurons innervating the circular muscle of guinea-pig ileum.

Authors:  S M Johnson; M Costa; C M Humphreys
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989 Jan-Feb       Impact factor: 3.000

7.  Light- and electron-microscopic immunochemical analysis of nerve fibre types innervating the taenia of the guinea-pig caecum.

Authors:  J B Furness; S Pompolo; C W Shuttleworth; D E Burleigh
Journal:  Cell Tissue Res       Date:  1992-10       Impact factor: 5.249

8.  The in vitro pharmacology of the peripherally restricted opioid receptor antagonists, alvimopan, ADL 08-0011 and methylnaltrexone.

Authors:  D T Beattie; M Cheruvu; N Mai; M O'Keefe; S Johnson-Rabidoux; C Peterson; E Kaufman; R Vickery
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-03-06       Impact factor: 3.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.